Clinical Trial Update: Study of 6-Thioguanine in Combination With 6-Mercaptopurine During Maintenance Therapy of Childhood Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

Withdrawal of a Phase 1/Phase 2 clinical trial evaluating the combination of 6-thioguanine and 6-mercaptopurine for maintenance therapy in childhood non-Hodgkin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• 6-mercaptopurine (6-mercaptopurine)
• 6-thioguanine (6-thioguanine)

Snippet

Sponsor: Kjeld Schmiegelow | Conditions: Non-Hodgkin Lymphoma | Phase 1, Phase 2 | Status: WITHDRAWN